An honest guide to startup valuation — the five methods investors use, current stage-by-stage benchmarks.
Startup valuation is not a spreadsheet output. It's a negotiation informed by comparables, stage benchmarks, and the specific investor's model.
The dominant method at seed and Series A. Investors look at what similar companies (same stage, sector, geo, growth rate) raised at recently. If seed rounds in your category are pricing at $10M–$18M post-money, that's your window — not your DCF.
Once you have real ARR, valuation becomes a multiple of that revenue — commonly 8×–20× ARR at Series A for software, adjusted for growth rate. Fast-growing SaaS (>100% YoY) commands higher multiples; slow growth compresses them fast.
Pre-revenue methods assign dollar values to qualitative factors (team, product, market, competitive advantage, execution risk). Rarely used by professional investors but common in angel groups and accelerators. Ceilings around $2M–$5M pre-money.
Investors work backwards from a target exit ($500M–$5B), a target ownership at exit (10–20%), and their target multiple (10×–30×). This gives them a maximum entry price. Useful to understand — it explains why some investors won't stretch on valuation even when metrics support it.
Rarely used at early stage — the inputs are too speculative. Occasionally invoked at growth-stage as a sanity check, but even then comparables dominate.
The 'right' valuation is the one that lets you close a round with the right lead investor while leaving enough ownership on the table for the next round. Chasing the highest number often means a longer raise, a worse lead, and a harder next round when you can't grow into the price.
Investor directory · Fundraising library · Articles A–Z · Company funding database